241 related articles for article (PubMed ID: 32336272)
1. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
3. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
6. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
[TBL] [Abstract][Full Text] [Related]
7. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
9. Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells.
Luo Y; Gui R
J Gynecol Oncol; 2020 Sep; 31(5):e75. PubMed ID: 32808501
[TBL] [Abstract][Full Text] [Related]
10. Plasma exosomal
Chen L; Wang K; Li L; Zheng B; Zhang Q; Zhang F; Chen J; Wang S
Future Oncol; 2022 Aug; 18(26):2919-2931. PubMed ID: 35893704
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
Tanaka Y; Kamohara H; Kinoshita K; Kurashige J; Ishimoto T; Iwatsuki M; Watanabe M; Baba H
Cancer; 2013 Mar; 119(6):1159-67. PubMed ID: 23224754
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Taylor DD; Gercel-Taylor C
Gynecol Oncol; 2008 Jul; 110(1):13-21. PubMed ID: 18589210
[TBL] [Abstract][Full Text] [Related]
13. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
[TBL] [Abstract][Full Text] [Related]
15. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
Wang L; He M; Fu L; Jin Y
Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
[TBL] [Abstract][Full Text] [Related]
17. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
[TBL] [Abstract][Full Text] [Related]
18. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
19. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]